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Background/aim: Embolus shedding is one of the important complications in carotid artery stenting (CAS). Carotid high-resolution magnetic
resonance imaging (HR-MRI) is often used to directly reflect important biological characteristics, such as plaque size and composition, as well
as the structure of the carotid artery wall. The aim of this study was to investigate the predictive values of carotid HR-MRI for large embolus
shedding in CAS.
Materials and methods: In total, 195 patients with carotid stenosis were enrolled. Preoperative carotid HR-MRI was performed to define the
nature of the carotid plaques. CAS was performed in all patients, and intraoperative embolic protection devices were used to collect the shed
emboli. According to the diameter and number of shed emboli, the patients were divided into the small-embolus group (group X) and largeembolus group (group Y). Logistic regression analysis was used to analyze the risk factors of large embolus shedding.
Results: Group Y included 58 patients, and group X included 137 patients. Age, stenosis length, smoking, and ≥3 transient cerebral ischemic
attacks were risk factors for large embolus shedding. Two cases of shed large emboli developed from stable plaques, and 56 cases of large emboli
developed from vulnerable plaques. When vulnerable plaques were associated with more risk factors, the incidences of large embolus shedding
in cases with vulnerable plaques combined with 0, 1, 2, 3, and 4 risk factors were 44 % (4/9), 68.1% (15/22), 72.2% (13/18), 76.5% (13/17), and
84.6% (11/13), respectively.
Conclusion: Carotid HR-MRI can predict the incidence of large embolus shedding in CAS.
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1. Introduction
Cerebral infarction (CI) is one of the main causes for the death
and disability in elderly individuals, and carotid stenosis is an
important risk factor for CI. It has been reported that about
26%–28% of patients with a carotid stenosis degree of 70%–
90% as well as cerebral ischemic symptoms will develop CI
within 1 year [1], and carotid stenosis-induced CI accounts
for 20% of CI cases [2]. Carotid artery stenting (CAS) and
carotid endarterectomy (CEA) are the two main surgical
methods used to manage carotid stenosis [3], and CEA has
always been considered as the "gold standard" treatment for
carotid artery stenosis. However, CAS has progressively
become the new technique that is most likely to replace CEA
[4,5]. One serious complication in CAS is lesion plaque
shedding, resulting in CI [6]. There still exist wide
controversies regarding whether applying cerebral protection
devices can reduce the occurrence of intra-CAS CI. Some
reports indicate that the use of embolic protection devices
(EPDs) can effectively reduce the occurrence of embolism
complications [6,7], but other reports indicate that the use of
EPDs not only effectively reduce, but also increase surgery
costs and protection device-induced complications, such as
vascular spasm and vascular dissection [8–10]. The most
important complication that causes death and disability in
*Correspondence: ljfwz007@sina.com

CAS is intraoperative embolus shedding-induced vascular
embolization [6].
Carotid high-resolution magnetic resonance imaging
(HR-MRI) can directly reflect important biological
characteristics such as plaque size and composition, as well as
the structure of the carotid artery wall. Carotid HR-MRI has
unique advantages in evaluating different types of
atherosclerotic plaques, especially in evaluating the stability of
vulnerable plaques, compared with those of other methods
[11]. Whether carotid HR-MRI can be used to assess patients’
carotid plaques to predict the incidence of embolus shedding
in advance — thus providing a reliable clinical basis for the
necessity of applying EPDs in high-risk patients — remains a
question. This study intended to find the risk factors for the
occurrence of large emboli combined with carotid HR-MRI to
provide clinical judgment of carotid plaque types before CAS,
predict the incidence of intraoperative embolus shedding, and
provide a basis for the application of EPDs.
2. Patients and methods
2.1. Patients
A total of 195 patients who underwent CAS in the Affiliated
Provincial Hospital between October 2012 and December
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2015 were enrolled. The inclusion criteria were as follows:
carotid stenosis ≥70%, symptomatic or asymptomatic poor
collateral circulation, and age >45 years. The exclusion criteria
were as follows: thrombocytopenia, <100×109/L; leucopenia,
<4×109/L; neutropenia; cerebral hemorrhage within nearly 3
months; allergic to aspirin or clopidogrel; severe heart or lung
disease; and bead-string-like CAS. If the patient newly
developed CI, the surgery was routinely delayed for 3 weeks.
If the patient did not present with symptom aggravation
within 3 weeks and diffusion-weighted imaging (DWI) or
computed tomography (CT) showed good absorption of the
new lesion or the lesion was significantly reduced than before,
the patients could undergo CAS. The study was supervised by
the Medical Ethics Committee of Shandong Provincial
Hospital Affiliated to Shandong First Medical University, and
all the patients or their legal guardians signed the informed
consent.
2.2. Perioperative preparation
All the patients underwent digital subtraction angiography
using one angiography instrument (Artis zee floor, Siemens,
Germany). After local anesthesia was administered, the
femoral artery was punctured using the Seldinger method,
and one 5F vascular sheath was implanted. The carotid and
vertebral arteries underwent arteriography in turn using the
catheter. Carotid stenosis was measured according to the
criteria of the North American Symptomatic Carotid
Endarterectomy Trial [12]. Before CAS, the patients with
carotid stenosis >70% selectively underwent carotid HR-MRI
(PHILIPS 3.0T, Philips, The Netherlands) with a carotid
dedicated 4-channel phased-array surface coil. The system
was positioned parallel to the line that connected the
anteroposterior edge of foramen magnum. Initial scans were
conducted using standard carotid 2D high-resolution MRI
sequences in order to obtain the initial position: axial 3D TOF
and 2D-BB-MRI placed at the center of the bilateral carotid
artery bifurcation and the 2 cm region around the center was
subsequently scanned. The plaque composition (lipid-rich
core, intraplaque hemorrhage, and calcification) and the
surface condition of the fibrous cap of the plaque (complete
or broken) in the common carotid artery, carotid bifurcation,
and internal carotid artery as references, were observed and
used to assess the stability of the plaque, which then were
divided into two groups: stable plaques and vulnerable
plaques. Stable plaques referred to types VII and VIII and
vulnerable plaques referred to types IV, V, and VI in the
American Heart Association (AHA) classification [13]. In
HR-MRI, vulnerable plaques are defined as the plaque lesions
that may progress rapidly to pathogenic lesions or plaques
with severe thrombotic tendency, i.e. type IV (atheroma), type
V (fibrous poroma), and type VI (complex plaque,
intracerebral hemorrhage) in the classification of
atherosclerosis (AS) [14–17]. The MRI signal performances of
types IV and V of the AHA classification (compared with the
sternocleidomastoid muscle at the same level) are as follows:
time-of-flight (TOF) images show iso-signal, T1-weighted
(T1W) images show iso-signal, T2-weighted (T2W) images
show low signal, and proton density weighted images (PDWI)
show low signal. The MRI signal performances of type VI
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[18,19] are as follows: fresh intraplaque hemorrhage and
recent hemorrhage. The MRI performances of fresh
intraplaque hemorrhage are as follows: TOF images show isosignal, T1W images show high signal, T2W images show low
or iso-signal, and PDWI show low or iso-signal. The MRI
performances of recent plague hemorrhage are as follows:
TOF images show high signal, T1W images show high signal,
T2W images show high signal, and PDWI show high signal.
Stable plaques are type VII (calcified plaque) and type VIII
(fibrous plaque) in the classification of AS plaques. The MRI
signals of type VII plaques showed low signals in T1WI,
T2WI, and PDWI; type VIII plaques showed iso-signal or
high signal on T1WI, slightly high or iso-signal on PDWI and
slightly high signal or iso-signal on T2WI [20]. As a
noninvasive method, HR-MRI can comprehensively evaluate
the functions and morphologies of different types of plaques
and then determine the potential rupture risks of different
types of plaques. Before surgery, 100 mg of aspirin and 75 mg
of clopidogrel were administered for at least 3 days.
2.3. Procedures of CAS
When performing CAS, the right femoral artery was first
punctured using the Seldinger method, and 4000–5000 units
of heparin saline (70 units/kg) was then injected together with
an intraoperative intravenous push of 2000 units of heparin
saline every other hour to ensure the heparinized state of the
whole body (even if the clotting time was maintained between
250 and 300 s). One 8F catheter was then inserted into the
stenotic vessel with its tip placed 20 mm below the stenosis. In
order to ensure that the maximum diameter of the cerebral
protection device (Accunet, Abbott, USA and Emboshield
NAV6, Abbott, USA) could safely pass through the stenosis, if
the residual luminal segment at the stenosis was <2 mm, a 2mm balloon system (Viatrac, Abbott, USA) was delivered via
a micro-wire to preexpand the stenosis.
After EPDs were successfully placed, the appropriate
balloons (Acculink, Abbott, USA) were used to preexpand the
stenosis, and after the expansion, the appropriate stents
(Acculink, Abbott, USA) were selected for CAS. After the stent
was released, if the residual vascular lumen was ≥30%, the
balloon system was reused for the post-stenting expansion to
achieve the purpose of reducing the residual vascular lumen
to <30%.
During stent release, the patient’s heart rate may decrease
rapidly, so the patient was asked to cough immediately after
the stent was released; if the heart rate still increased slowly 10
s later, atropine (maximum dose, 0.5 mg) was intravenously
injected immediately. If the intraoperative blood pressure
dropped, there was no need to increase the blood pressure
immediately, and observation alone could be performed if no
symptoms appeared. If the blood pressure dropped to 90/60
mmHg or less, dopamine (3–10 μg·kg–1·min–1) could be
administered to increase the blood pressure and to ensure that
the systolic blood pressure was not less than 90 mmHg.
Meanwhile, the systolic blood pressure could not exceed 120
mmHg to prevent hypertension-induced high perfusion
syndrome. After releasing the stent, EPDs were carefully
recycled, marked, and recorded correspondingly for the
statistical analysis later.
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2.4. Postoperative treatment
After CAS, the patient was sent back to the ward for at least
24-h electrocardiogram monitoring; meanwhile, the heart rate
and blood pressure were strictly monitored, and pressor or
anti-hypertensive agent doses were adjusted according to the
blood pressure and heart rate. If intraoperative headache or
ineffective limb activity developed, the surgery was
discontinued immediately and neurological examination was
performed. If positive signs were found, intraoperative Carm-assisted brain scans were performed. If the above
symptoms appeared postoperatively, CT was performed to
exclude cerebral hemorrhage.
2.5. Out-of-hospital medication
Each patient was orally administered 75 mg of clopidogrel and
100 mg of aspirin routinely for 3 months after discharge. The
patients were instructed to return for clinical follow-up in the
1st, 3rd, and 6th months for guidance and adjustment of the
medication doses.
2.6. Grouping of emboli and patients
The emboli were divided into four types: A, no shed embolus
was found within the protection device; B, the embolic
diameter within the protection device was <2 mm, and the
number was ≤2; C, the embolic diameter within the protection
device was <2 mm, but the number was ≥3; and D, the embolic
diameter within the protection device was ≥2 mm, and the
number was ≥1 (Figure 1). According to the reported criteria
[21], types C and D emboli were defined as large emboli and

types A and B emboli as small emboli. According to the types
of the emboli, the patients were divided into two groups: group
X (with types A and B emboli) and group Y (with types C and
D emboli). The numbers of large and small emboli were
counted when vulnerable plaques were combined with
different risk factors to calculate the probability of the
occurrence of large emboli.
2.7. Statistical analysis
SPSS 17.0 software (SPSSInc., Chicago, IL, USA) was used
for the statistical analysis. Logistic regression analysis was
used to compare the characteristics and disease history of the
patients to determine the risk factors that might result in the
occurrence of large emboli during CAS. The p value <0.05 was
defined as statistically significant.
3. Results
3.1. Preoperative carotid HR-MRI manifestations
Before surgery, carotid HR-MRI showed that, of 195 patients,
116 patients had stable plaques and 79 patients had vulnerable
plaques (Figure 2).
3.2. Overall treatment outcomes
A total of 195 patients successfully underwent CAS. The
procedure of CAS is shown in Figure 3. During surgery, EPDs
were used in all patients. It was difficult to directly withdraw
the EPDs in 26 patients. After rotating the neck, swallowing,
or pressing the neck, the EPDs were finally successfully
withdrawn.

Figure 1. Emboli collected from intraoperative embolus protection devices. The arrows referred to the collected emboli. A: type A, no
embolus was found; B: type B, 2 or less emboli with the diameter < 2 mm; C: type C, 3 or more emboli with the diameter < 2 mm; D: type
D: more than 1 embolus with the diameter ≥ 2 mm.
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Figure 2. C-HR-MRI revealed vulnerable plaques (type VI: intraplaque hemorrhage). The plaque was presented by the arrow. The C-HRMRI manifestations of type VI AS (intraplaque hemorrhage) were high-signal T1 and TOF images, as well as high-, iso-, or low-signal T2
and PD images.

3.3. Collection of emboli
After surgery, 58 cases of large emboli and 137 cases of small
emboli were collected using EPDs. Among 58 cases of large
emboli, 56 cases involved vulnerable plaques and 2 cases
involved stable plaques.
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3.4. Complications
On the day of the surgery, hyperperfusion symptoms occurred
in 6 patients. Two patients had intracranial hemorrhage on the
day and on the second day of surgery, respectively.
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Figure 3. Procedures of CAS. A: The arrow showed severe stenosis at the right internal carotid artery. B: The arrow showed the embolic
protection device. C: The arrow showed that stenosis was alleviated after applying balloon dilatation at the severely stenotic site of right
carotid artery. D: The arrow showed that the intra-carotid artery stenosis was significantly alleviated after releasing the intra-carotid stent.

3.5. Logistic regression analysis of major embolic risk factors
Logistic regression analysis of the risk factors of large emboli
is shown in Table 1. The lateral neck angle is shown in Figure
4. Logistic regression analysis showed that the age (p =
0.0465), stenosis length (p = 0.0475), smoking (p = 0.0102),
and ≥3 preoperative transient cerebral ischemic attacks (p =
0.0172) were the risk factors of large embolus shedding.

3.6. Incidences of large embolus shedding for vulnerable
plaques combined with risk factors
The incidences of large embolus shedding for vulnerable
plaques combined with risk factors are shown in Table 2. The
incidences of large embolus shedding in the cases with
vulnerable plaques combined with 0, 1, 2, 3, and 4 risk factors
were 44% (4/9), 68.1% (15/22), 72.2% (13/18), 76.5% (13/17),
and 84.6% (11/13), respectively.
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Table 1. Logistic regression analysis of major embolic risk factors.
Index

Small-embolus group (n = 137)

Large-embolus group (n = 58)

P

Age

60.52 ± 5.57

72.49 ± 5.24

0.0465

Male [n(%)]

97 (70.8%)

53 (91.4%)

Female [n(%)]

38 (29.2%)

5 (8.6%)

Hypertension [n(%)]

64 (46.7%)

24 (41.4%)

0.3010

Diabetes [n(%)]

45 (32.8%)

27 (46.6%)

0.4654

Stenosis length (mm)

13.44 ± 3.95

19.32 ± 6.18

0.0475

Vascular stenosis rate (%)

79.68 ± 9.38

82.80 ± 9.32

0.4221

Lateral neck angle (Figure 4)

135.27 ± 17.84

149.04 ± 16.05

0.5132

Drinking [n(%)]

75 (54.7%)

38 (65.5%)

0.4534

Smoking [n(%)]

37 (27%)

35 (60.3%)

0.0102

TIA ≥ 3 [n(%)]
TIA, transient cerebral ischemic attack.

25 (18.2%)

40 (69%)

0.0172

Sex

0.2199

Figure 4. Lateral neck angle: the angle between Line A and B.
Table 2. Incidences of large embolus shedding when vulnerable
plaques combined with different risk factors.
Number of
Large
Small
Incidence of
Cases
risk factor
embolus
embolus
large embolus
0
9
4
5
44.4%
1

22

15

7

68.1%

2

18

13

5

72.2%

3

17

13

4

76.5%

4

13

11

2

84.6%

Total

79

56

23
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4. Discussion
Presently, there exist controversies about the two main
surgical methods of carotid stenosis, namely CAS and CEA.
However, the Carotid Revascularization Endarterectomy
versus Stenting Trial (CREST) shows that complications such
as stroke, myocardial infarction, or mortality occurred in the
two methods are not significantly different, but CAS has
greater advantages for intra-carotid stenosis in high-cervical
and intracranial segments [4].
Esposito-Bauer et al. [22] performed carotid HR-MRI in
77 asymptomatic patients with carotid stenosis, and all these
patients were followed up for 41.1 months. Nine patients
(11.7%) exhibited stenosis-ipsilateral CI, but the patients with
stable plaques did not develop cerebrovascular events during
the follow-up. Esposito-Bauer et al. [22] showed that carotid
HR-MRI has high sensitivity in judging vulnerable plaques
and can be used to determine whether patients will develop
transient ischemic attack or stroke in the future. The
incidence of acute ischemic cerebrovascular events is closely
related to vulnerable plaques. Takaya et al. [23] pointed out
that the occurrence of ischemic cerebrovascular events in
patients with vulnerable plaques is likely to be related to the
vulnerable plaque rupture or vulnerable plaque combined
with thrombosis. Gröschel et al. [24] retrospectively analyzed
176 patients who underwent CAS, and the results showed that
old age (>80 years) and plaque length are risk factors for new
infarction. Sayeed et al. [25] studied and analyzed 421 patients
who underwent CAS and found that when the plaque length
of carotid stenosis is >15 mm, the likelihood of concurrent
infarction is greater. This study confirmed that in addition to
the age (p = 0.0465), stenosis length (p = 0.0475), and
smoking (p = 0.0102), ≥3 preoperative transient ischemic
attack episodes (p = 0.0172) are a risk factor for large
embolus shedding.
In this study, 26 patients had difficulties recovering with
the use of an EPD, which was finally solved after allowing
these patients to turn their necks, perform a swallowing
action, or pressing the neck. Müller-Hülsbeck et al. [26]
indicated that the carotid arteries in which EPDs were applied
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in pig carotid stenosis models exhibited varying degrees of
micro-injuries in the vascular wall. In one clinical analysis by
Lian et al. [3], 30 (15.4%) of 195 patients who underwent CAS
exhibited difficulties in recovering with the use of EPDs,
among whom 29 patients finally recovered after long-term
attempts and one patient recovered following EPD removal
via surgery. Cremonesi et al. [27] and Shilling et al. [28] also
reported cases with difficult EPD removal for devices entering
the edge of the stent or those that were stuck in the stent and
were finally removed surgically. Lian et al. [3] showed that
type VII plaques (namely calcified plagues) or carotid artery
torsion angle >80° are risk factors for difficulties in
intraoperative EPD recovery. If the above factors exist, it is
likely for approximately 15.4% of cases of intra-CAS EPDs to
experience retrieval difficulties (13.3% in this study), and
surgical removal of EPDs is necessary in rare cases. Based on
fluently implementing CAS, assessing the application
indications of EPDs and independent risk factors for difficult
EPD recovery can exhibit important roles in reducing EPDinduced complications.
Our statistical results showed that when vulnerable
plaques were associated with different numbers of risk factors,
the probabilities of the incidence of large emboli are different.
Given the results of this single-center trial, vulnerable plaques
(associated with or without risk factors of large embolus
shedding) are important indications for the application of
EPDs. Therefore, we recommend that the patients with
vulnerable plaques should receive EPDs during CAS. Carotid
HR-MRI also showed that 116 of the 195 patients had stable
plaques, and finally, 2 large emboli were observed in cases
with stable plaques, with an incidence of large emboli of 1.7%.
The incidence of large emboli in cases with stable plaques is
low, so not applying EPDs can be considered. However, small
emboli have clinical uncertainty in patients with stable
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